USPTO serial 79347334
BYRYZN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 30, 2024
- Examiner
- BULLOFF, TOBY ELLEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BYRYZN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Diane J. Mason
Diane J. Mason Faegre Drinker Biddle & Reath LLPFour Embarcadero Center, 27th FloorSan Francisco, CA 94111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetics; functional cosmetics being non-medicated skin care preparations; anti-aging cosmetic preparations; cosmetic preparations for skin renewal; cosmetic preparations for skin care; wrinkle-minimizing cosmetic preparations for topical facial use; non-medicated skin ointment; anti-wrinkle creams; wrinkle removing skin care preparations; age retardant gels for cosmetic use; mask pack for cosmetic purposes; pores tightening mask packs used as cosmetics; essential oils; lotions for face and body care; toilet water; Make-up bases, namely, Make-up primer and Make-up foundation; whitening essences for skincare; sun block; cosmetics for face washes; cosmetic lip care creams | ACTIVE | — |
| 005 | Injectable dermal fillers; hyaluronic acid mixed with its derivatives and other polysaccharides, including or not including lidocaine, in ampoule form for medical purposes; hyaluronic acid preparations for medical purposes; pharmaceutical preparations mainly based on hyaluronic acid for improving skin tone and texture; hyaluronic acid preparations for medical purposes in the form of prefilled injectable pharmaceuticals; pre-filled syringes for medical purposes containing saline for rehydrating the skin, pharmaceuticals for dissolving skin wrinkles; filled syringes for medical purposes containing pharmaceuticals for rehydrating the skin, dissolving skin wrinkles; drugs for medical purposes for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis and cerebral palsy; drugs for medical purposes for the treatment of sports injuries, namely, injured or torn skin, muscle, ligaments or bone; drugs for medical purposes for the treatment of tremors, namely, spasmodic smooth, striated or cardiac muscles; drugs for medical purposes for the treatment of pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmacological preparations for skin care; tissue-regenerative pharmaceutical preparations; dermatological pharmaceutical products; pharmaceutical preparations for the treatment of wrinkles; medicated skin care preparations; tissues impregnated with pharmaceutical lotions for skin conditions, sunburn; medicated ointments for treating dermatological conditions; medicated lotions and creams for the body, skin, face, and hands; pharmacological preparations for cosmetic treatment, namely, medicated cosmetics; medicated skin lotions; modified hyaluronic acid preparations for medical purposes; medical topical gels for activation of skin tissues; medicines for treating dermatological conditions; filler for urological purposes being injectable dermal fillers; self injection syringes for medical purposes for injection of prefilled hyaluronic acid; pharmacological preparations for cosmetic surgery, namely, anesthetics for surgery, medicated ointment for treating dermatological conditions; filler for plastic surgery being injectable dermal fillers; biological biomaterials for tissue restoration for medical purposes; filler for dermatology being injectable dermal fillers; implants comprising living tissue; skin grafts | ACTIVE | — |
| 010 | Medical apparatus for injecting fillers; bone void fillers comprised of artificial materials; filler injectors for medical purposes; injection device for pharmaceuticals; syringes for medical purposes; disposable hypodermic syringes for medical use; hypodermic syringes for use in administering injection substances; syringes for injections; medical apparatus and instruments for the treatment of skin; medical apparatus and instruments for plastic surgery; artificial implants for skin regeneration; artificial skin for surgical purposes; medical skin enhancement apparatus using lasers; medical esthetic machine for skin massage; medical apparatus for skin wrinkle removal; medical apparatus and instruments for urological purposes; medical apparatus which includes a syringe for introducing pharmaceutical preparations into the human body; artificial implants for medical, surgical, urological, dermatological and plastic surgery; Medical instruments, namely, surgical thread; Medical instruments, namely, laser instruments for medical use; Medical apparatus and instruments, namely, surgical apparatus and instruments; medical bone prostheses; electric injection apparatus which includes a filler injector for medical purposes; dermic implants including visco-supplementation substances for medical use, intended for wrinkle filling or volume increasing, namely, artificial skin for surgical use; Medical apparatus, namely, lasers for the cosmetic treatment of the face and skin; Medical apparatus, namely, electronic light therapy apparatus for the skin; medical apparatus and instruments for dermatological use; syringes for injection of medical substances for the skin used for injection of a hyaluronic acid gel in a pre-filled syringe for reducing wrinkles, filling scars and contouring the lips and face | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HUGEL INC.
- Other trademarks owned by HUGEL INC.
- Other trademarks owned by HUGEL INC.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named BYRYZN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 11, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 27, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 2, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 2, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 30, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 5, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 30, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 30, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 17, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 17, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 14, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 14, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 25, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 25, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 25, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 6, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 5, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 5, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 25, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 5, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 5, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 17, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 16, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 15, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 16, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 12, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 11, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |